APA
Bartlett N. L., Chen R., Fanale M. A., Brice P., Gopal A., Smith S. E., Advani R., Matous J. V., Ramchandren R., Rosenblatt J. D., Huebner D., Levine P., Grove L. & Forero-Torres A. (20150102). Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. : Journal of hematology & oncology.
Chicago
Bartlett Nancy L, Chen Robert, Fanale Michelle A, Brice Pauline, Gopal Ajay, Smith Scott E, Advani Ranjana, Matous Jeffrey V, Ramchandren Radhakrishnan, Rosenblatt Joseph D, Huebner Dirk, Levine Pamela, Grove Laurie and Forero-Torres Andres. 20150102. Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. : Journal of hematology & oncology.
Harvard
Bartlett N. L., Chen R., Fanale M. A., Brice P., Gopal A., Smith S. E., Advani R., Matous J. V., Ramchandren R., Rosenblatt J. D., Huebner D., Levine P., Grove L. and Forero-Torres A. (20150102). Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. : Journal of hematology & oncology.
MLA
Bartlett Nancy L, Chen Robert, Fanale Michelle A, Brice Pauline, Gopal Ajay, Smith Scott E, Advani Ranjana, Matous Jeffrey V, Ramchandren Radhakrishnan, Rosenblatt Joseph D, Huebner Dirk, Levine Pamela, Grove Laurie and Forero-Torres Andres. Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. : Journal of hematology & oncology. 20150102.